Trial Information

Experimentation of New Organizational Models of Cervical Cancer Screening Programs, Upon the Use of HPV Test as First Level: Evaluation of the Methodologies Proposed of the Use of Self-sampling Devices to Recover Non-responders.

In a previous trial (ISRCTN96071600) the investigators tested on 2400 women, compliance with
self sampler device (PantaRhei Devices, Zeist, the Netherlands).

With this study the investigators analyze the response to two channels of transmission of
the device (a model of device easier, and less expensive than the previous), such as
screening for colon cancer.

The shipment of the device at home and taking on a local pharmacy. Involving 15000 women
non-responders to previous calls in five different screening programs in Italy (Rome,
Bologna, Abruzzo region, Molise region, Veneto region).